Tumour markers in breast carcinoma correlate with grade rather than with invasiveness

British Journal of Cancer

Volumn 85, Issue 6, 2001, Pages 869-874

  Warnberg F ^a   Nordgren, H ^a   Bergkvist, L ^b   Holmberg, L ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

^c Uppsala Orebro Regional Oncologic Center   (Sweden)

Author keywords

Breast cancer; In situ; Invasive; Progression

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; ONCOPROTEIN; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53; TUMOR MARKER;

ADULT; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CARCINOMA IN SITU; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL DIFFERENTIATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035860140     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1995     Document Type: Article

References (22)

1. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancel
2. New aspects of the natural history of in situ and invasive carcinoma in the female breast. Results from autopsy investigations
3. Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome
4. Comparative genomic hybridization of ductal carcinoma in situ of the breast - Evidence of multiple genetic pathways
5. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): Correlation with grade of associated invasive carcinoma
6. Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: Experience from a large study with long term follow up
7. Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast
8. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer
9. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis
10. Breast conserving surgery in the management of in situ breast carcinoma
11. Microvessel density and distribution in ductal carcinoma in situ of the breast
12. The clinical of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ)
13. Ductal carcinoma in situ: A proposal for a new classification
14. Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer
15. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 Protein
16. Intraductal carcinoma of the breast: Follow-up after biopsy only
17. Duct carcinoma in situ: Predictors of local recurrence and progression in patients treated by surgery alone
18. The clinical significance of pre-invasive breast carcinoma
19. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast
20. C-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma
21. Clinically occult ductal carcinoma in situ detected with mammography: Analysis of 100 cases with radiologic-pathologic correlation
22. Ductal carcinoma in situ